 |
Education 2002-Present: Contact |
My research focuses on developing a novel technology to generate organic and inorganic nanoparticles protected by biocompatible polymers with precisely controlled size and size distribution (reference). My study of the long term stability of the nanoparticles demonstrated that the fundamental mass transfer phenomena of Ostwald ripening could quantitatively predict and explain the time evolution of nanoparticles (reference). As a practical application, we formulate the anti-tuberculosis drug, rifampicin, into nanoparticles by conjugation to other hydrophobic molecules to increase the drug loading and sustain drug release, and collaborate with Professor David Edwards at Harvard University to spray dry the nanoparticle suspension to form porous micro-particles for aerosol drug delivery (reference). |
|
